The 72 kDa matrix metalloproteinase (MMP-2) and the 92kDa matrix metalloproteinase (MMP-9), are type IV collagenases that have been implicated as important factors in cancer invasion and metastasis formation. We have used quantitative zymography and computer-assisted image analysis to measure the levels of MMP-9 and MMP-2 in 19 samples of serum of lung cancer patients and in 23 samples of normal serum. Mean levels of MMP-9 were significantly elevated in cancer samples compared with normal sera (1.33 ± 0.61 μU μl-1 vs. 0.37 ± 0.10 μU μl-1, P<0.0001). MMP-2 levels did not differ significantly in these two groups. However, there was no significant correlation between serum MMP-9 activity and the disease stage. We found that circulation levels of MMP-9 in lung cancer patients is 3.6-fold higher than in healthy volunteers, however, we do not consider this elevation to be a direct reflection of MMP-9 over-production by tumour cells. © 2001 Harcourt Publishers Ltd.
CITATION STYLE
Hrabec, E., Strek, M., Nowak, D., & Hrabec, Z. (2001). Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer. Respiratory Medicine, 95(1), 1–4. https://doi.org/10.1053/rmed.2000.0923
Mendeley helps you to discover research relevant for your work.